Stakeholder Views on Self-Injection of DMPA-SC in Senegal and Uganda

In 2014, PATH conducted interviews with stakeholders in Senegal and Uganda to assess receptivity to self-injection of subcutaneous contraceptive Sayana Press as well as the evidence requirements and processes necessary to chart a course for adoption, introduction, and scale-up of self-injection as a service-delivery practice in the two countries.

Publication date: August 2016

Stakeholder Views on Self-Injection of DMPA-SC in Senegal and Uganda

379.9 KB PDF

Hard copies are available.

View Resource